These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34755040)

  • 21. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The COVID-19 Vaccination Hesitancy Among the People With Inflammatory Bowel Disease in China: A Questionnaire Study.
    Wu X; Lin J; Buch H; Ding Q; Zhang F; Cui B; Ji G
    Front Public Health; 2021; 9():731578. PubMed ID: 34708016
    [No Abstract]   [Full Text] [Related]  

  • 24. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications.
    Targownik LE; Bernstein CN; Lakatos PL; Murthy SK; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Jones JL; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Windsor JW; Panaccione R
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S40-S45. PubMed ID: 34755038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Caldera F; Balzora S; Hayney MS; Farraye FA; Cross RK
    Inflamm Bowel Dis; 2021 Oct; 27(10):1703-1705. PubMed ID: 34013958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
    Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
    [No Abstract]   [Full Text] [Related]  

  • 30. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care.
    Jones JL; Benchimol EI; Bernstein CN; Huang JG; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Kaplan GG; Kuenzig ME; Tandon P; Targownik LE; Windsor JW; Bitton A
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S61-S67. PubMed ID: 34755041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
    Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
    Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.
    Elkharsawi A; Arnim UV; Schmelz R; Sander C; Stallmach A; Teich N; Walldorf J; Reuken PA
    Z Gastroenterol; 2022 Jan; 60(1):77-80. PubMed ID: 35042256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease.
    Orfanoudaki E; Zacharopoulou E; Kitsou V; Karmiris K; Theodoropoulou A; Mantzaris GJ; Tzouvala M; Michopoulos S; Zampeli E; Michalopoulos G; Karatzas P; Viazis N; Liatsos C; Bamias G; Koutroubakis IE; On Behalf Of The Hellenic Group For The Study Of Ibd
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists.
    Papa A; Scaldaferri F; Vetrone LM; Neri M; Gasbarrini A; Lopetuso LR
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33808983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over Time.
    Coward S; Windsor JW; Kuenzig ME; Bitton A; Bernstein CN; Jones JL; Khanna R; Lee K; Murthy SK; Targownik L; Benchimol E; Huang JG; Mukhtar MS; Tandon P; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S20-S26. PubMed ID: 34755035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.
    Bianchi FP; Polignano M; Carella N; Rotolo O; Curlo M; Mastronardi M
    Hum Vaccin Immunother; 2024 Dec; 20(1):2349319. PubMed ID: 38755111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.